Divi's Laboratories Ltd. (DIVI)

3,705.20
+11.55(+0.31%)
  • Volume:
    433,599
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    3,658.00 - 3,739.90

DIVI Overview

Prev. Close
3,693.65
Day's Range
3,658-3,739.9
Revenue
86.96B
Open
3,739.9
52 wk Range
3,365.55-5,425.1
EPS
116.97
Volume
433,599
Market Cap
983.61B
Dividend (Yield)
30.00
(0.81%)
Average Vol. (3m)
461,269
P/E Ratio
30.67
Beta
0.318
1-Year Change
-22.79%
Shares Outstanding
265,468,580
Next Earnings Date
Nov 07, 2022
What is your sentiment on Divi's Labs?
or
Market is currently closed. Voting is open during market hours.

Divi's Laboratories Ltd. News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Divi's Laboratories Ltd. Analysis

  • Panacea Shares Up Despite Nifty Decline
    • ByFSM News-

    Why shares of the biotech company are rising despite a plunge in the shares of pharma and metal sectors Despite the Nifty and the Sensex Index posting rebounds in the shares of...

  • The Diverse Income Trust

    Popular Performer2012 was a successful year for The Diverse Income Trust (DIVI), as, in total return terms, its share price rose by 39.1% vs 12.3% for the FTSE All-Share Index....

Divi's Laboratories Ltd. Company Profile

Divi's Laboratories Ltd. Company Profile

Employees
16818
Market
India
  • Type:Equity
  • Market:India
  • ISIN:INE361B01024
  • S/N:DIVISLAB

Divi's Laboratories Limited is an India-based company, which is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. The Company’s subsidiaries include Divi’s Laboratories USA, Inc., (Divi’s USA) and Divi’s Laboratories Europe AG (Divi’s Europe).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyBuy
Technical IndicatorsSellStrong BuyBuyStrong BuyStrong Sell
SummaryNeutralStrong BuyStrong BuyStrong BuyNeutral
  • Expiry of August around 3900
    0
    • sure sir
      0
  • Divi Labs 4200 very
    0
    • why
      0
  • dnt think so ...it might touch 3000
    0
    • divis lab target June 4100
      0
      • divis lab target by March expiry 2022
        0
        • It can go for 4000-4100 in coming days.
          0
          • high resistance and strong profit booking zone at 4400, moreover US has sanctioned some audits on health sector so going to be bearish soon.
            1
            • ROCKET 🚀 GOD BLESS...... TARGET 5800/6200/6500/7500/8500 SPLIT..........& INFINITY
              0
              • Buy this level target 6000 January
                0
                • buy divi target 4800 sl 4500
                  0